Synteract scores contract for brain cancer trial
California-based Synteract has scored a clinical trial management contract from Northwest Biotherapeutics to bring one of the world's first personalised medicines into a late stage clinical trial.
California-based Synteract has scored a clinical trial management contract from Northwest Biotherapeutics to bring one of the world's first personalised medicines into a late stage clinical trial.
Large global contract research organisation, SFBC International, has changed its name to PharmaNet Development Group in a bid to make a fresh start and turnaround the troubled business after a long period of bad press, legal difficulties and poor...
PPD International has launched a new software system that it claims can speed up the review time of safety and endpoint-driven data from large-scale clinical trials or registries.
Bruised by Novartis's snub over a $600m (€466m) vaccine plant, Maryland has commissioned a study on what more the state can do to attract a major cell culture vaccine manufacturing facility there.
The recovery that has taken packaging and processing machinery company IMA to profitability in 2006 has continued, helped by new opportunities in the biotech sector and a strong growth in generics.
Seattle drug firm ZymoGenetics has taken Bristol-Myers Squibb (BMS) to court for infringement of its fusion protein technology patents by several products, including arthritis medication Orencia (abatacept).